BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 29755452)

  • 1. Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions.
    Hsu AC
    Front Immunol; 2018; 9():743. PubMed ID: 29755452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
    Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.
    Nogales A; Martinez-Sobrido L; Chiem K; Topham DJ; DeDiego ML
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
    Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate and adaptive immune responses against Influenza A Virus: Immune evasion and vaccination strategies.
    Varghese PM; Kishore U; Rajkumari R
    Immunobiology; 2022 Nov; 227(6):152279. PubMed ID: 36272344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination.
    Park HS; Liu G; Thulasi Raman SN; Landreth SL; Liu Q; Zhou Y
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.
    Turkington HL; Juozapaitis M; Tsolakos N; Corrales-Aguilar E; Schwemmle M; Hale BG
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of innate immunity and its perturbation by influenza viruses.
    Goraya MU; Wang S; Munir M; Chen JL
    Protein Cell; 2015 Oct; 6(10):712-21. PubMed ID: 26206138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response.
    Kesavardhana S; Samir P; Zheng M; Malireddi RKS; Karki R; Sharma BR; Place DE; Briard B; Vogel P; Kanneganti TD
    J Biol Chem; 2021; 296():100579. PubMed ID: 33766561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-Virus Interaction: How Host Cells Defend against Influenza A Virus Infection.
    Zhang Y; Xu Z; Cao Y
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32235330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.
    Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B
    J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
    Hsu SF; Su WC; Jeng KS; Lai MM
    J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on the nonstructural protein 1 (NS1) of influenza a virus.
    Zhang X; Zhang Y; Wei F
    Virulence; 2024 Dec; 15(1):2359470. PubMed ID: 38918890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
    Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the risk of pandemic influenza virus evolution by mutation and re-assortment.
    Reperant LA; Grenfell BT; Osterhaus AD
    Vaccine; 2015 Dec; 33(49):6955-66. PubMed ID: 26603954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A virus PB1-F2 protein: An ambivalent innate immune modulator and virulence factor.
    Cheung PH; Lee TT; Chan CP; Jin DY
    J Leukoc Biol; 2020 May; 107(5):763-771. PubMed ID: 32323899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity and virulence of influenza.
    Liang Y
    Virulence; 2023 Dec; 14(1):2223057. PubMed ID: 37339323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
    Sun H; Blackmon S; Yang G; Waters K; Li T; Tangwangvivat R; Xu Y; Shyu D; Wen F; Cooley J; Senter L; Lin X; Jarman R; Hanson L; Webby R; Wan XF
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral RNA polymerase: a promising antiviral target for influenza A virus.
    Shi F; Xie Y; Shi L; Xu W
    Curr Med Chem; 2013; 20(31):3923-34. PubMed ID: 23931274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.